Literature DB >> 20203525

An extensive comparison of quantitative trait Loci mapping methods.

A Kleensang1, D Franke, A Alcaïs, L Abel, B Müller-Myhsok, A Ziegler.   

Abstract

BACKGROUND: The choices of study design and statistical approach for mapping a quantitative trait (QT) are of great importance. Larger sibships and a study design based upon phenotypically extreme siblings can be expected to have a greater statistical power. On the other hand, selected samples and/or deviation from normality can influence the robustness and power. Unfortunately, the effects of violation of multivariate normality assumptions and/or selected samples are only known for a limited number of methods. Some recommendations are available in the literature, but an extensive comparison of robustness and power under several different conditions is lacking.
METHODS: We compared eight freely available and commonly applied QT mapping methods in a Monte-Carlo simulation study under 36 different models and study designs (three genetic models, three selection schemes, two family structures and the possible effect of deviation from normality).
RESULTS: Empirical type I error fractions and empirical power are presented and explained as a whole and for each method separately, followed by a thorough discussion.
CONCLUSIONS: The results from this extensive comparison could serve as a valuable source for the choice of the study design and the statistical approach for mapping a QT. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20203525     DOI: 10.1159/000289596

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  8 in total

1.  Computationally efficient multipoint linkage analysis on extended pedigrees for trait models with two contributing major Loci.

Authors:  Ming Su; Elizabeth A Thompson
Journal:  Genet Epidemiol       Date:  2012-06-27       Impact factor: 2.135

2.  Linkage and association of phospholipid transfer protein activity to LASS4.

Authors:  Elisabeth A Rosenthal; James Ronald; Joseph Rothstein; Ramakrishnan Rajagopalan; Jane Ranchalis; G Wolfbauer; John J Albers; John D Brunzell; Arno G Motulsky; Mark J Rieder; Deborah A Nickerson; Ellen M Wijsman; Gail P Jarvik
Journal:  J Lipid Res       Date:  2011-07-13       Impact factor: 5.922

3.  QTL replication and targeted association highlight the nerve growth factor gene for nonverbal communication deficits in autism spectrum disorders.

Authors:  A T-H Lu; J Yoon; D H Geschwind; R M Cantor
Journal:  Mol Psychiatry       Date:  2011-11-22       Impact factor: 15.992

4.  Ecological genetics and genomics of plant defenses: Evidence and approaches.

Authors:  Jill T Anderson; Thomas Mitchell-Olds
Journal:  Funct Ecol       Date:  2011-04       Impact factor: 5.608

5.  Genome scan in familial late-onset Alzheimer's disease: a locus on chromosome 6 contributes to age-at-onset.

Authors:  Wei Zhao; Elizabeth E Marchani; Charles Y K Cheung; Ellen J Steinbart; Gerard D Schellenberg; Thomas D Bird; Ellen M Wijsman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-01-25       Impact factor: 3.568

Review 6.  Review: toxicometabolomics.

Authors:  Mounir Bouhifd; Thomas Hartung; Helena T Hogberg; Andre Kleensang; Liang Zhao
Journal:  J Appl Toxicol       Date:  2013-05-30       Impact factor: 3.446

7.  Multipoint genome-wide linkage scan for nonword repetition in a multigenerational family further supports chromosome 13q as a locus for verbal trait disorders.

Authors:  D T Truong; L D Shriberg; S D Smith; K L Chapman; A R Scheer-Cohen; M M C DeMille; A K Adams; A Q Nato; E M Wijsman; J D Eicher; J R Gruen
Journal:  Hum Genet       Date:  2016-08-17       Impact factor: 4.132

8.  Genetic Candidate Variants in Two Multigenerational Families with Childhood Apraxia of Speech.

Authors:  Beate Peter; Ellen M Wijsman; Alejandro Q Nato; Mark M Matsushita; Kathy L Chapman; Ian B Stanaway; John Wolff; Kaori Oda; Virginia B Gabo; Wendy H Raskind
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.